Name of Depositor
Fred Hutchinson Cancer Res. Cntr.
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Weiler SR, et al. D3: a gene induced during myeloid cell differentiation of Linlo c-Kit+ Sca-1(+) progenitor cells. Blood 93: 527-536, 1999. PubMed: 9885214
Tsai S, Collins SJ. Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors. US Patent 5,830,760 dated Nov 3 1998
Scott LM, et al. E3, a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha. Blood 88: 2517-2530, 1996. PubMed: 8839844
Johnson BS, et al. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol. Cell. Biol. 19: 3372-3382, 1999. PubMed: 10207061
Du Y, et al. Identification of an interleukin-3-regulated aldoketo reductase gene in myeloid cells which may function in autocrine regulation of myelopoiesis. J. Biol. Chem. 275: 6724-6732, 2000. PubMed: 10702227
Lawson ND, et al. Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines. Exp. Hematol. 26: 1178-1185, 1998. PubMed: 9808058
Lawson ND, et al. Isolation and characterization of the cDNA for mouse neutrophil collagenase: demonstration of shared negative regulatory pathways for neutrophil secondary granule protein gene expression. Blood 91: 2517-2524, 1998. PubMed: 9516153